Permeability factors in nephrotic syndrome and focal segmental glomerulosclerosis

Kidney Research and Clinical Practice

Volumn 31, Issue 4, 2012, Pages 205-213

  Savin, Virginia J ^a   McCarthy, Ellen T ^a   Sharma, Mukut ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cytokines; Focal glomerulosclerosis; Galactose; Kidney transplantation; Plasmapheresis; Proteinuria

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ADALIMUMAB; ALPHA ACTININ; ANTILIPEMIC AGENT; ATORVASTATIN; B7 ANTIGEN; CARDIOTROPHIN LIKE CYTOKINE 1; CORTICOSTEROID; CORTICOTROPIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; GALACTOSE; IMMUNOGLOBULIN; INTERLEUKIN 6; LISINOPRIL; LOSARTAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEPHRIN; PODOCIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN A; PUROMYCIN AMINONUCLEOSIDE; RITUXIMAB; ROSIGLITAZONE; STEROID; TACROLIMUS; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CAUSAL ATTRIBUTION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; FOCAL GLOMERULOSCLEROSIS; GENE MUTATION; HIV ASSOCIATED NEPHROPATHY; HUMAN; IMMUNOADSORPTION; IMMUNOTHERAPY; KIDNEY ALLOGRAFT; NEPHROTIC SYNDROME; NONHUMAN; PHARMACOLOGICAL BLOCKING; PLASMAPHERESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RECURRENT DISEASE; REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 84879192089     PISSN: 22119132     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.krcp.2012.10.002     Document Type: Review

References (83)

1. S.A. Mendoza, and B.M. Tune Management of the difficult nephrotic patient Pediatr Clin North Am 42 1995 1459 1468
2. D. Cattran, T. Neogi, R. Sharma, E.T. McCarthy, and V.J. Savin Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis J Am Soc Nephrol 14 2003 448 453
3. D.C. Cattran, E. Alexopoulos, P. Heering, P.F. Hoyer, A. Johnston, A. Meyrier, C. Ponticelli, T. Saito, G. Choukroun, P. Nachman, M. Praga, and N. Yoshikawa Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations Kidney Int 72 2007 1429 1447
4. R. Bhimma, M. Adhikari, K. Asharam, and C. Connolly Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus Am J Nephrol 26 2006 544 551
5. N. Duncan, A. Dhaygude, J. Owen, T.D. Cairns, M. Griffith, A.G. McLean, A. Palmer, and D. Taube Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy Nephrol Dial Transplant 19 2004 3062 3067
6. A. Bagga, P. Hari, A. Moudgil, and S.C. Jordan Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome Am J Kidney Dis 42 2003 1114 1120
7. P. Ravani, A. Magnasco, A. Edefonti, L. Murer, R. Rossi, L. Ghio, E. Benetti, F. Scozzola, A. Pasini, N. Dallera, F. Sica, M. Belingheri, F. Scolari, and G.M. Ghiggeri Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial Clin J Am Soc Nephrol 6 2011 1308 1315
8. A. Fornoni, J. Sageshima, C. Wei, S. Merscher-Gomez, R. Aguillon-Prada, A.N. Jauregui, J. Li, A. Mattiazzi, G. Ciancio, L. Chen, G. Zilleruelo, C. Abitbol, J. Chandar, W. Seeherunvong, C. Ricordi, M. Ikehata, M.P. Rastaldi, J. Reiser, and G.W. Burke 3rd: Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis Sci Transl Med 3 2011 46 85
9. A.S. Bomback, J.A. Tumlin, J. Baranski, J.E. Bourdeau, A. Besarab, A.S. Appel, J. Radhakrishnan, and G.B. Appel Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel Drug Des Devel Ther 5 2011 147 153
10. D.S. Gipson, S.F. Massengill, L. Yao, S. Nagaraj, W.E. Smoyer, J.D. Mahan, D. Wigfall, P. Miles, L. Powell, J.J. Lin, H. Trachtman, and L.A. Greenbaum Management of childhood onset nephrotic syndrome Pediatrics 124 2009 747 757
11. R. Dall'Amico, G. Ghiggeri, M. Carraro, M. Artero, L. Ghio, E. Zamorani, C. Zennaro, G. Basile, G. Montini, L. Rivabella, M. Cardillo, M. Scalamogna, and F. Ginevri Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children Am J Kidney Dis 34 1999 1048 1055
12. M. Kestilä, U. Lenkkeri, M. Männikkö, J. Lamerdin, P. McCready, H. Putaala, V. Ruotsalainen, T. Morita, M. Nissinen, R. Herva, C.E. Kashtan, L. Peltonen, C. Holmberg, A. Olsen, and K. Tryggvason Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome Mol Cell 1 1998 575 582
13. R. Gbadegesin, P. Lavin, J. Foreman, and M. Winn Pathogenesis and therapy of focal segmental glomerulosclerosis: an update Pediatr Nephrol 26 2011 1001 1015
14. M.P. Winn, P.J. Conlon, K.L. Lynn, M.K. Farrington, T. Creazzo, A.F. Hawkins, N. Daskalakis, S.Y. Kwan, S. Ebersviller, J.L. Burchette, M.A. Pericak-Vance, D.N. Howell, J.M. Vance, and P.B. Rosenberg A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis Science 308 2005 1801 1804
15. J. Radhakrishnan, R.N. Uppot, and R.B. Colvin Case records of the Massachusetts General Hospital. Case 5-2010. A 51-year-old man with HIV infection, proteinuria, and edema N Engl J Med 362 2010 636 646
16. C.M. Wyatt, K. Meliambro, and P.E. Klotman Recent progress in HIV-associated nephropathy Annu Rev Med 63 2012 147 159
17. A. Moudgil, C.C. Nast, A. Bagga, L. Wei, A. Nurmamet, A.H. Cohen, S.C. Jordan, and M. Toyoda Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy Kidney Int 59 2001 2126 2133
18. T. Bertani, G. Rocchi, G. Sacchi, G. Mecca, and G. Remuzzi Adriamycin-induced glomerulosclerosis in the rat Am J Kidney Dis 7 1986 12 19
19. C.I. Whiteside, R. Cameron, S. Munk, and J. Levy Podocytic cytoskeletal disaggregation and basement-membrane detachment in puromycin aminonucleoside nephrosis Am J Pathol 142 1993 1641 1653
20. G.S. Markowitz, G.B. Appel, P.L. Fine, A.Z. Fenves, N.R. Loon, S. Jagannath, J.A. Kuhn, A.D. Dratch, and V.D. D'Agati Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate J Am Soc Nephrol 12 2001 1164 1172
21. V.J. Savin, R. Sharma, H.B. Lovell, and D.J. Welling Measurement of albumin reflection coefficient with isolated rat glomeruli J Am Soc Nephrol 3 1992 1260 1269
22. M. Sharma, R. Sharma, E.T. McCarthy, and V.J. Savin The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects Exp Biol Med 229 2004 85 98
23. R. Sharma, M. Sharma, E.T. McCarthy, X.L. Ge, and V.J. Savin Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro Kidney Int 58 2000 1973 1979
24. E.T. McCarthy, R. Sharma, and M. Sharma Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier Kidney Int 67 2005 152 156
25. M. Sharma, E.T. McCarthy, D.S. Reddy, P.K. Patel, V.J. Savin, M. Medhora, and J.R. Falck 8,9-Epoxyeicosatrienoic acid protects the glomerular filtration barrier Prostaglandins Other Lipid Mediat 89 2009 43 51
26. R. Sharma, and V.J. Savin Cyclosporine prevents the increase in glomerular albumin permeability caused by serum from patients with focal segmental glomerular sclerosis Transplantation 61 1996 381 383
27. G. Lagrue, A. Branellec, C. Blanc, S. Xheneumont, F. Beaudoux, A. Sobel, and B. Weil A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties Biomedicine 23 1975 73 75
28. W.W. Bakker, C.M. van Dael, L.J. Pierik, J.A. van Wijk, J. Nauta, T. Borghuis, and J.J. Kapojos Altered activity of plasma hemopexin in patients with minimal change disease in relapse Pediatc Nephrol 20 2005 1410 1415
29. K. Matsumoto, and K. Kanmatsuse Interleukin-18 and interleukin-12 synergize to stimulate the production of vascular permeability factor by T lymphocytes in normal subjects and in patients with minimal-change nephrotic syndrome Nephron 85 2000 127 133
30. K. Matsumoto, and K. Kanmatsuse Transforming growth factor-beta1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome Nephron 87 2001 111 117
31. W.W. Bakker, T. Borghuis, M.C. Harmsen, A. van den Berg, I.P. Kema, K.E. Niezen, and J.J. Kapojos Protease activity of plasma hemopexin Kidney Int 68 2005 603 610
32. R. Lennon, A. Singh, G.I. Welsh, R.J. Coward, S. Satchell, L. Ni, P.W. Mathieson, W.W. Bakker, and M.A. Saleem Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes J Am Soc Nephrol 19 2008 2140 2149
33. W.W. Bakker, R.B. Donker, A. Timmer, M.G. van Pampus, W.J. van Son, J.G. Aarnoudse, H. van Goor, K.E. Niezen-Koning, G. Navis, T. Borghuis, R.M. Jongman, and M.M. Faas Plasma hemopexin activity in pregnancy and preeclampsia Hypertens Pregnancy 26 2007 227 239
34. P.K. Cheung, P.A. Klok, J.F. Baller, and W.W. Bakker Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin Kidney Int 57 2000 1512 1520
35. E.H. Garin, W. Mu, J.M. Arthur, C.J. Rivard, C.E. Araya, M. Shimada, and R.J. Johnson Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis Kidney Int 78 2010 296 302
36. E.T. McCarthy, M. Sharma, and V.J. Savin Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis Clin J Am Soc Nephrol 5 2010 2115 2121
37. C. Wei, S. El Hindi, J. Li, A. Fornoni, N. Goes, J. Sageshima, D. Maiguel, S.A. Karumanchi, H.K. Yap, M. Saleem, Q. Zhang, B. Nikolic, A. Chaudhuri, P. Daftarian, E. Salido, A. Torres, M. Salifu, M.M. Sarwal, F. Schaefer, C. Morath, V. Schwenger, M. Zeier, V. Gupta, D. Roth, M.P. Rastaldi, G. Burke, P. Ruiz, and J. Reiser Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis Nat Med 17 2011 952 960
38. J. Eugen-Olsen, O. Andersen, A. Linneberg, S. Ladelund, T.W. Hansen, A. Langkilde, J. Petersen, T. Pielak, L.N. Moller, J. Jeppesen, S. Lyngbaek, M. Fenger, M.H. Olsen, P.R. Hildebrandt, K. Borch-Johnsen, T. Jorgensen, and S.B. Haugaard Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population J Intern Med 268 2010 296 308
39. T. Sehestedt, S. Lyngbæk, J. Eugen-Olsen, J. Jeppesen, O. Andersen, T.W. Hansen, A. Linneberg, T. Jorgensen, S.B. Haugaard, and M.H. Olsen Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events Atherosclerosis 216 2011 237 243
40. K. Pawlak, B. Ulazka, M. Mysliwiec, and D. Pawlak Vascular endothelial growth factor and uPA/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis? Transl Res 160 2012 346 354
41. S. Hariharan, and V.J. Savin Recurrent and de novo disease after renal transplantation: a report from the Renal Allograft Disease Registry Pediatr Transplant 8 2004 349 357
42. J.R. Hoyer, R.L. Vernier, J.S. Najarian, L. Raij, R.L. Simmons, and A.F. Michael Recurrence of idiopathic nephrotic syndrome after renal transplantation. 1972 J Am Soc Nephrol 12 2001 1994 2002
43. S. Hariharan Recurrent and de novo diseases after renal transplantation Semin Dial 13 2000 195 199
44. R.N. Fine Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children Pediatric Nephrol 22 2007 496 502
45. V.J. Savin, R. Sharma, M. Sharma, E.T. McCarthy, S.K. Swan, E. Ellis, H. Lovell, B. Warady, S. Gunwar, A.M. Chonko, M. Artero, and F. Vincenti Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis N Engl J Med 334 1996 878 883
46. H. Trachtman, L.A. Greenbaum, E.T. McCarthy, M. Sharma, B.G. Gauthier, R. Frank, B. Warady, and V.J. Savin Glomerular permeability activity: prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome Am J Kidney Dis 44 2004 604 610
47. E.T. McCarthy, M. Sharma, R. Sharma, R.J. Falk, and J.C. Jennette Sera from patients with collapsing focal segmental glomerulosclerosis increase albumin permeability of isolated glomeruli J Lab Clin Med 143 2004 225 229
48. M.L. Artero, R. Sharma, V.J. Savin, and F. Vincenti Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis Am J Kidney Dis 23 1994 574 581
49. C.D. Garcia, V.B. Bittencourt, A. Tumelero, J.S. Antonello, D. Malheiros, and V.D. Garcia Plasmapheresis for recurrent posttransplant focal segmental glomerulosclerosis Transplant Proc 38 2006 1904 1905
50. J. Dantal, E. Bigot, W. Bogers, A. Testa, F. Kriaa, Y. Jacques, B. Hurault de Ligny, P. Niaudet, B. Charpentier, and J.P. Soulillou Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome N Engl J Med 330 1994 7 14
51. M. Haas, Y. Godfrin, R. Oberbauer, N. Yilmaz, K. Borchhardt, H. Regele, W. Druml, K. Derfler, and G. Mayer Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis Nephrol Dial Transplant 13 1998 2013 2016
52. R. Grenda, W. Jarmużek, B. Pia̧tosa, and J. Rubik Long-term effect of rituximab in maintaining remission of recurrent and plasmapheresis-dependent nephrotic syndrome post-renal transplantation - case report Pediatr Transplant 15 2011 E121 E125
53. L.A. Greenbaum, R. Benndorf, and W.E. Smoyer Childhood nephrotic syndrome-current and future therapies Nat Rev Nephrol 8 2012 445 458
54. R. Sharma, M. Sharma, X. Ge, E.T. McCarthy, and V.J. Savin Cyclosporine protects glomeruli from FSGS factor via an increase in glomerular cAMP Transplantation 62 1996 1916 1920
55. C. Faul, M. Donnelly, S. Merscher-Gomez, Y.H. Chang, S. Franz, J. Delfgaauw, J.M. Chang, H.Y. Choi, K.N. Campbell, K. Kim, J. Reiser, and P. Mundel The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A Nat Med 14 2008 931 938
56. R.Y. Gohh, A.F. Yango, P.E. Morrissey, A.P. Monaco, A. Gautam, M. Sharma, E.T. McCarthy, and V.J. Savin Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients Am J Transplant 5 2005 2907 2912
57. A. Belson, P.D. Yorgin, A.Y. Al-Uzri, O. Salvatierra, J. Higgins, and S.R. Alexander Long-term plasmapheresis and protein A column treatment of recurrent FSG Pediatr Nephrol 16 2001 985 989
58. K. Suthar, A.V. Vanikar, and H.L. Trivedi Renal transplantation in primary focal segmental glomerulosclerosis using a tolerance induction protocol Transplant Proc 40 2008 1108 1110
59. V. Guigonis, A. Dallocchio, V. Baudouin, M. Dehennault, C. Hachon-Le Camus, M. Afanetti, J. Groothoff, B. Llanas, P. Niaudet, H. Nivet, N. Raynaud, S. Taque, P. Ronco, and F. Bouissou Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases Pediatr Nephrol 23 2008 126 1279
60. M.D. Pescovitz, B.K. Book, and R.A. Sidner Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment N Engl J Med 354 2006 1961 1963
61. S.W. Zimmerman Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation Clin Nephrol 22 1984 32 38
62. M. Bruschi, P. Catarsi, G. Candiano, M.P. Rastaldi, L. Musante, F. Scolari, M. Artero, M. Carraro, A. Carrea, G. Caridi, C. Zennaro, S. Sanna-Cherchi, F.B. Viola, F. Ferrario, F. Perfumo, and G.M. Ghiggeri Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis Kidney Int 63 2003 686 695
63. R.J. Coward, R.R. Foster, D. Patton, L. Ni, R. Lennon, D.O. Bates, S.J. Harper, P.W. Mathieson, and M.A. Saleem Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes J Am Soc Nephrol 16 2005 629 637
64. J.L. Hunt, M.R. Pollak, and B.M. Denker Cultured podocytes establish a size-selective barrier regulated by specific signaling pathways and demonstrate synchronized barrier assembly in a calcium switch model of junction formation J Am Soc Nephrol 16 2005 1593 1602
65. A.A. Pegoraro, A.K. Singh, J.A. Arruda, G. Dunea, and A.A. Bakir A simple method to detect and albumin permeability factor in the idiopathic nephrotic syndrome Kidney Int 58 2000 1342 1345
66. M.A. Saleh, E.I. Boesen, J.S. Pollock, V.J. Savin, and D.M. Pollock Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes Diabetologia 54 2011 979 988
67. A.J. Dahly-Vernon, M. Sharma, E.T. McCarthy, V.J. Savin, S.R. Ledbetter, and R.J. Roman Transforming growth factor-beta, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats Hypertension 45 2005 643 648
68. M. Sharma, R. Sharma, X.L. Ge, B.L. Fish, E.T. McCarthy, V.J. Savin, E.P. Cohen, and J.E. Moulder Early detection of radiation-induced glomerular injury by albumin permeability assay Radiat Res 155 2001 474 480
69. V.J. Savin, and D.A. Terreros Filtration in single isolated mammalian glomeruli Kidney Int 20 1981 188 197
70. M. Carraro, G. Caridi, M. Bruschi, M. Artero, R. Bertelli, C. Zennaro, L. Musante, G. Candiano, F. Perfumo, and G.M. Ghiggeri Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome J Am Soc Nephrol 13 2002 1946 1952
71. M. Sharma, R. Sharma, E.T. McCarthy, and V.J. Savin The FSGS factor:" enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma J Am Soc Nephrol 10 1999 552 561
72. V.J. Savin, E.T. McCarthy, R. Sharma, D. Charba, and M. Sharma Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity Transl Res 151 2008 288 292
73. T. Srivastava, R.E. Garola, M. Kestila, K. Tryggvason, V. Ruotsalainen, M. Sharma, V.J. Savin, H. Jalanko, and B.A. Warady Recurrence of proteinuria following renal transplantation in congenital nephrotic syndrome of the Finnish type Pediatr Nephrol 21 2006 711 718
74. E.T. McCarthy, and M. Sharma Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum Kidney Int 61 2002 534 541
75. M. Sharma, E.T. McCarthy, V.J. Savin, and E.A. Lianos Nitric oxide preserves the glomerular protein permeability barrier by antagonizing superoxide Kidney Int 68 2005 2735 2744
76. M. Sharma, J.Z. Li, R. Sharma, M. Artero, X. Ge, E.T. McCarthy, H.Y. Wang, and V. Savin Inhibitory effect of Tripterygium wilfordii multiglycoside on increased glomerular albumin permeability in vitro Nephrol Dial Transplant 12 1997 2064 2068
77. D.S. Gipson, H. Trachtman, F.J. Kaskel, T.H. Greene, M.K. Radeva, J.J. Gassman, M.M. Moxey-Mims, R.J. Hogg, S.L. Watkins, R.N. Fine, S.L. Hogan, J.P. Middleton, V.M. Vehaskari, P.A. Flynn, L.M. Powell, S.M. Vento, J.L. McMahan, N. Siegel, V.D. D'Agati, and A.L. Friedman Clinical trial of focal segmental glomerulosclerosis in children and young adults Kidney Int 80 2011 868 878
78. A. Peyser, N. Machardy, F. Tarapore, J. Machardy, L. Powell, D.S. Gipson, V. Savin, C. Pan, T. Kump, S. Vento, and H. Trachtman Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group BMC Nephrol 11 2010 2
79. M.S. Joy, D.S. Gipson, M. Dike, L. Powell, A. Thompson, S. Vento, A. Eddy, A.B. Fogo, J.B. Kopp, D. Cattran, and H. Trachtman Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group Clin J Am Soc Nephro 4 2009 39 47
80. M.S. Joy, D.S. Gipson, L. Powell, J. MacHardy, J.C. Jennette, S. Vento, C. Pan, V. Savin, A. Eddy, A.B. Fogo, J.B. Kopp, D. Cattran, and H. Trachtman Phase 1 trial of adalimumab in focal segmental glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group Am J Kidney Dis 55 2010 50 60
81. E. De Smet, J.P. Rioux, H. Ammann, C. Déziel, and S. Quérin FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy Nephrol Dial Transplant 24 2009 2938 2940
82. H. Trachtman, F.C. Fervenza, D.S. Gipson, P. Heering, D.R. Jayne, H. Peters, S. Rota, G. Remuzzi, L.C. Rump, L.K. Sellin, J.P. Heaton, J.B. Streisand, M.L. Hard, S.R. Ledbetter, and F. Vincenti A phase 1, single-dose study of fresolimumab, an anti-TGF-beta antibody, in treatment-resistant primary focal segmental glomerulosclerosis Kidney Int 79 2011 1236 1243
83. G. Benoit, E. Machuca, and C. Antignac Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations Pediatr Nephrol 25 2010 1621 1632